$SRDX
SURMODICS INC

2024 Q3 Form 10-Q Financial Statement

#000095017024088249 Filed on July 31, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $33.23M $30.34M
YoY Change 18.8% -42.19%
Cost Of Revenue $8.674M $8.448M
YoY Change 23.23% 22.06%
Gross Profit $24.55M $21.89M
YoY Change 17.3% -51.95%
Gross Profit Margin 73.89% 72.16%
Selling, General & Admin $14.58M $16.63M
YoY Change 13.84% 29.15%
% of Gross Profit 59.38% 75.95%
Research & Development $9.702M $9.765M
YoY Change 0.06% -13.06%
% of Gross Profit 39.51% 44.6%
Depreciation & Amortization $2.139M $2.126M
YoY Change -0.6% -1.16%
% of Gross Profit 8.71% 9.71%
Operating Expenses $25.17M $26.39M
YoY Change 7.63% 9.28%
Operating Profit -$613.0K -$5.369M
YoY Change -74.98% -125.07%
Interest Expense $879.0K
YoY Change -215.2%
% of Operating Profit
Other Income/Expense, Net -$524.0K -$442.0K
YoY Change -42.07%
Pretax Income -$1.137M -$5.811M
YoY Change -59.23% -128.14%
Income Tax $2.312M $1.700M
% Of Pretax Income
Net Earnings -$3.449M -$7.554M
YoY Change -151.52% -202.83%
Net Earnings / Revenue -10.38% -24.9%
Basic Earnings Per Share -$0.53
Diluted Earnings Per Share -$0.24 -$0.53
COMMON SHARES
Basic Shares Outstanding 14.27M 14.26M
Diluted Shares Outstanding 14.17M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $40.11M $38.18M
YoY Change -11.55% -14.37%
Cash & Equivalents $36.12M $24.30M
Short-Term Investments $3.997M $13.87M
Other Short-Term Assets $2.860M $2.718M
YoY Change -52.66% -57.54%
Inventory $15.17M $15.41M
Prepaid Expenses $2.752M $2.718M
Receivables $23.16M $13.39M
Other Receivables $0.00 $647.0K
Total Short-Term Assets $81.30M $80.36M
YoY Change -6.21% -6.4%
LONG-TERM ASSETS
Property, Plant & Equipment $24.96M $25.32M
YoY Change -4.11% -14.83%
Goodwill $44.64M $43.36M
YoY Change 3.94% -1.12%
Intangibles $23.57M $23.70M
YoY Change -10.06% -14.73%
Long-Term Investments
YoY Change
Other Assets $4.093M $4.681M
YoY Change 5.93% 178.13%
Total Long-Term Assets $97.26M $97.06M
YoY Change -1.8% -5.82%
TOTAL ASSETS
Total Short-Term Assets $81.30M $80.36M
Total Long-Term Assets $97.26M $97.06M
Total Assets $178.6M $177.4M
YoY Change -3.86% -6.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.786M $3.186M
YoY Change -6.92% 28.26%
Accrued Expenses $3.795M $5.428M
YoY Change -41.11% -59.14%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $20.54M $20.20M
YoY Change -14.24% -36.98%
LONG-TERM LIABILITIES
Long-Term Debt $29.55M $29.52M
YoY Change 0.51% 0.56%
Other Long-Term Liabilities $9.568M $7.785M
YoY Change 18.71% -40.26%
Total Long-Term Liabilities $39.12M $7.785M
YoY Change 385.38% -81.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $20.54M $20.20M
Total Long-Term Liabilities $39.12M $7.785M
Total Liabilities $59.67M $59.27M
YoY Change -9.36% -22.51%
SHAREHOLDERS EQUITY
Retained Earnings $75.71M $79.16M
YoY Change -13.23% -1.74%
Common Stock $45.31M $43.10M
YoY Change 21.1% 22.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $118.9M $118.1M
YoY Change
Total Liabilities & Shareholders Equity $178.6M $177.4M
YoY Change -3.86% -6.08%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$3.449M -$7.554M
YoY Change -151.52% -202.83%
Depreciation, Depletion And Amortization $2.139M $2.126M
YoY Change -0.6% -1.16%
Cash From Operating Activities $3.658M -$2.033M
YoY Change 191.71% -107.85%
INVESTING ACTIVITIES
Capital Expenditures $542.0K $959.0K
YoY Change -27.54% 104.04%
Acquisitions
YoY Change
Other Investing Activities $10.00M -$5.763M
YoY Change -356.15%
Cash From Investing Activities $9.458M -$6.722M
YoY Change -303.31% 1330.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.562M 66.00K
YoY Change -475.48% -447.37%
NET CHANGE
Cash From Operating Activities 3.658M -2.033M
Cash From Investing Activities 9.458M -6.722M
Cash From Financing Activities -1.562M 66.00K
Net Change In Cash 11.55M -8.689M
YoY Change -487.46% -134.21%
FREE CASH FLOW
Cash From Operating Activities $3.658M -$2.033M
Capital Expenditures $542.0K $959.0K
Free Cash Flow $3.116M -$2.992M
YoY Change 515.81% -111.77%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0000924717
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q2 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2024#ProductMember
CY2023Q2 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2024#ProductMember
us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2024#ProductMember
us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2024#ProductMember
CY2024Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2023Q3 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2024Q2 us-gaap Derivative Instrument Gain Loss Reclassified From Aoci Into Income Effective Portion Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
CY2023Q2 us-gaap Derivative Instrument Gain Loss Reclassified From Aoci Into Income Effective Portion Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
us-gaap Derivative Instrument Gain Loss Reclassified From Aoci Into Income Effective Portion Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
us-gaap Derivative Instrument Gain Loss Reclassified From Aoci Into Income Effective Portion Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-23837
dei Entity Registrant Name
EntityRegistrantName
Surmodics, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MN
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-1356149
dei Entity Address Address Line1
EntityAddressAddressLine1
9924 West 74th Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Eden Prairie
dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55344
dei City Area Code
CityAreaCode
952
dei Local Phone Number
LocalPhoneNumber
500-7000
dei Security12b Title
Security12bTitle
Common Stock, $0.05 par value
dei Trading Symbol
TradingSymbol
SRDX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14267000
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24301000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
41419000
CY2024Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
13874000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
3933000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
106000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
80000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13390000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10850000
CY2024Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
10021000
CY2023Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
7796000
CY2024Q2 us-gaap Inventory Net
InventoryNet
15405000
CY2023Q3 us-gaap Inventory Net
InventoryNet
14839000
CY2023Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
491000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3365000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7363000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
80356000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
86691000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25319000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26026000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23702000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
26206000
CY2024Q2 us-gaap Goodwill
Goodwill
43355000
CY2023Q3 us-gaap Goodwill
Goodwill
42946000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4681000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3864000
CY2024Q2 us-gaap Assets
Assets
177413000
CY2023Q3 us-gaap Assets
Assets
185733000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3186000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2993000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7858000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10139000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5428000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6444000
CY2024Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3681000
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4378000
CY2024Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
43000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
20196000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
23954000
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
29517000
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
29405000
CY2023Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2400000
CY2024Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1771000
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2004000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7785000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8060000
CY2024Q2 us-gaap Liabilities
Liabilities
59269000
CY2023Q3 us-gaap Liabilities
Liabilities
65823000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.05
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.05
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
450000
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
450000
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14265000
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14265000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14155000
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14155000
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
713000
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
708000
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
42382000
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
36706000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4113000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4759000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
79162000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
87255000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
118144000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
119910000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
177413000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
185733000
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30341000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
52483000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
92851000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
104614000
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8448000
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6921000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
24352000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17926000
CY2024Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
9765000
CY2023Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
11232000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
28658000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
36899000
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16627000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12874000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
42257000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
39077000
CY2024Q2 srdx Acquisition Related Intangible Asset Amortization
AcquisitionRelatedIntangibleAssetAmortization
870000
CY2023Q2 srdx Acquisition Related Intangible Asset Amortization
AcquisitionRelatedIntangibleAssetAmortization
879000
srdx Acquisition Related Intangible Asset Amortization
AcquisitionRelatedIntangibleAssetAmortization
2616000
srdx Acquisition Related Intangible Asset Amortization
AcquisitionRelatedIntangibleAssetAmortization
2659000
us-gaap Restructuring Charges
RestructuringCharges
1282000
CY2023Q2 srdx Contingent Consideration Expense Gain
ContingentConsiderationExpenseGain
-835000
srdx Contingent Consideration Expense Gain
ContingentConsiderationExpenseGain
-829000
CY2024Q2 us-gaap Costs And Expenses
CostsAndExpenses
35710000
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
31071000
us-gaap Costs And Expenses
CostsAndExpenses
97883000
us-gaap Costs And Expenses
CostsAndExpenses
97014000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5369000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
21412000
us-gaap Operating Income Loss
OperatingIncomeLoss
-5032000
us-gaap Operating Income Loss
OperatingIncomeLoss
7600000
CY2024Q2 us-gaap Interest Expense
InterestExpense
879000
CY2023Q2 us-gaap Interest Expense
InterestExpense
884000
us-gaap Interest Expense
InterestExpense
2656000
us-gaap Interest Expense
InterestExpense
2594000
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-51000
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-61000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-168000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-261000
CY2024Q2 us-gaap Investment Income Net
InvestmentIncomeNet
488000
CY2023Q2 us-gaap Investment Income Net
InvestmentIncomeNet
182000
us-gaap Investment Income Net
InvestmentIncomeNet
1487000
us-gaap Investment Income Net
InvestmentIncomeNet
531000
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-442000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-763000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1337000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2324000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5811000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
20649000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6369000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5276000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1743000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13303000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1724000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13506000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-7554000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
7346000
us-gaap Net Income Loss
NetIncomeLoss
-8093000
us-gaap Net Income Loss
NetIncomeLoss
-8230000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.53
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.59
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.53
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.57
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.59
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14170000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14050000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14141000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14020000
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14170000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14072000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14141000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14020000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-7554000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
7346000
us-gaap Net Income Loss
NetIncomeLoss
-8093000
us-gaap Net Income Loss
NetIncomeLoss
-8230000
CY2024Q2 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Before Adjustments After Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
149000
CY2023Q2 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Before Adjustments After Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
607000
us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Before Adjustments After Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
-45000
us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Before Adjustments After Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
-141000
CY2024Q2 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Adjustments After Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
61000
CY2023Q2 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Adjustments After Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
39000
us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Adjustments After Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
185000
us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Adjustments After Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax
19000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-6000
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-451000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
45000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
882000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
6833000
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-363000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
613000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
646000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6673000
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7917000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7959000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7447000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1557000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
123950000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-7554000
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-363000
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
93000
CY2024Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
26000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2044000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
118144000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
102554000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
7346000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
613000
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
16000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1915000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
112412000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
119910000
us-gaap Net Income Loss
NetIncomeLoss
-8093000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
646000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
450000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
213000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1120000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6138000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
118144000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
108392000
us-gaap Net Income Loss
NetIncomeLoss
-8230000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6673000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
453000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
350000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
888000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5662000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
112412000
us-gaap Profit Loss
ProfitLoss
-8093000
us-gaap Profit Loss
ProfitLoss
-8230000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6555000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6365000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6138000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5662000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
599000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
485000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
227000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
274000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
26000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
163000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-829000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-262000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-187000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
458000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-124000
srdx Increase Decrease In Accounts Receivable And Contract With Customer Asset
IncreaseDecreaseInAccountsReceivableAndContractWithCustomerAsset
5533000
srdx Increase Decrease In Accounts Receivable And Contract With Customer Asset
IncreaseDecreaseInAccountsReceivableAndContractWithCustomerAsset
1825000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
566000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2790000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3965000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
961000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
185000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-669000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3249000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2474000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
153000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
15583000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3097000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1427000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3410000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9264000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2950000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2170000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
25445000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
16000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12395000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2170000
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
10000000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
29664000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
614000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
663000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
803000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1120000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
888000
srdx Payments For Acquisition Of In Process Research And Development
PaymentsForAcquisitionOfInProcessResearchAndDevelopment
931000
srdx Payments For Acquisition Of In Process Research And Development
PaymentsForAcquisitionOfInProcessResearchAndDevelopment
978000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1388000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17987000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
75000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
500000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-17118000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
25581000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
41419000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18998000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24301000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
44579000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1679000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
251000
us-gaap Interest Paid Net
InterestPaidNet
2288000
us-gaap Interest Paid Net
InterestPaidNet
2157000
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
58000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
845000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Ultimate results could differ from those estimates. The results of operations for the three and nine months ended June 30, 2024 are not necessarily indicative of the results that may be expected for the entire 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> fiscal year.</span></p>
CY2024Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
10800000
CY2023Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
7800000
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3700000
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
6800000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3400000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3900000
CY2024Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
13883000
CY2024Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
9000
CY2024Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
13874000
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
3936000
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3933000
CY2024Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
9116000
CY2023Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
8063000
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
2162000
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
2607000
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4127000
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4169000
CY2024Q2 us-gaap Inventory Net
InventoryNet
15405000
CY2023Q3 us-gaap Inventory Net
InventoryNet
14839000
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2718000
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2600000
CY2024Q2 srdx Irish Research And Development Credits Receivable
IrishResearchAndDevelopmentCreditsReceivable
647000
CY2023Q3 srdx Irish Research And Development Credits Receivable
IrishResearchAndDevelopmentCreditsReceivable
1322000
CY2023Q3 srdx Cares Act Employee Retention Credit Receivable
CARESActEmployeeRetentionCreditReceivable
3441000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3365000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7363000
CY2024Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
48617000
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
24915000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
23702000
CY2023Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
48107000
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
21901000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
26206000
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
900000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
900000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2800000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2900000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
933000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
3696000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2810000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2562000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2551000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2551000
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
8019000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
23122000
CY2023Q3 us-gaap Goodwill
Goodwill
42946000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
409000
CY2024Q2 us-gaap Goodwill
Goodwill
43355000
CY2024Q2 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
750000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4681000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3864000
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
467000
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
178000
CY2024Q2 srdx Accrued Clinical Study Expense Current
AccruedClinicalStudyExpenseCurrent
701000
CY2023Q3 srdx Accrued Clinical Study Expense Current
AccruedClinicalStudyExpenseCurrent
1056000
CY2024Q2 srdx Accrued Purchases Current
AccruedPurchasesCurrent
1021000
CY2023Q3 srdx Accrued Purchases Current
AccruedPurchasesCurrent
1142000
CY2024Q2 srdx Deferred Consideration Current
DeferredConsiderationCurrent
1750000
CY2023Q3 srdx Deferred Consideration Current
DeferredConsiderationCurrent
2661000
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1021000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
872000
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
468000
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
535000
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5428000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6444000
CY2024Q2 srdx Deferred Consideration Liability Noncurrent
DeferredConsiderationLiabilityNoncurrent
1653000
CY2023Q3 srdx Deferred Consideration Liability Noncurrent
DeferredConsiderationLiabilityNoncurrent
1629000
CY2024Q2 srdx Unrecognized Tax Benefits Including Accrued Interest And Penalties
UnrecognizedTaxBenefitsIncludingAccruedInterestAndPenalties
2951000
CY2023Q3 srdx Unrecognized Tax Benefits Including Accrued Interest And Penalties
UnrecognizedTaxBenefitsIncludingAccruedInterestAndPenalties
3332000
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2915000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2974000
CY2024Q2 srdx Other Noncurrent
OtherNoncurrent
266000
CY2023Q3 srdx Other Noncurrent
OtherNoncurrent
125000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7785000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8060000
CY2024Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
30000000
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
30000000
CY2024Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
483000
CY2023Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
595000
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
29517000
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
29405000
CY2024Q1 srdx Accumulated Gain Loss Cash Flow Hedge
AccumulatedGainLossCashFlowHedge
-135000
CY2023Q3 srdx Accumulated Gain Loss Cash Flow Hedge
AccumulatedGainLossCashFlowHedge
183000
CY2024Q2 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Before Adjustments And Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
149000
CY2023Q2 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Before Adjustments And Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
607000
us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Before Adjustments And Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
-45000
us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Before Adjustments And Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
-141000
CY2024Q2 srdx Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Before Tax
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionBeforeTax
-61000
CY2023Q2 srdx Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Before Tax
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionBeforeTax
-39000
srdx Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Before Tax
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionBeforeTax
-185000
srdx Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Before Tax
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionBeforeTax
-19000
CY2024Q2 srdx Accumulated Gain Loss Cash Flow Hedge
AccumulatedGainLossCashFlowHedge
-47000
CY2023Q2 srdx Accumulated Gain Loss Cash Flow Hedge
AccumulatedGainLossCashFlowHedge
568000
CY2024Q2 srdx Accumulated Gain Loss Cash Flow Hedge
AccumulatedGainLossCashFlowHedge
-47000
CY2023Q2 srdx Accumulated Gain Loss Cash Flow Hedge Qtd
AccumulatedGainLossCashFlowHedgeQtd
-160000
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2044000
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1915000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6138000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5662000
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
13100000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y3M18D
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14170000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14050000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14141000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14020000
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
22000
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14170000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14072000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14141000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14020000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1700000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13300000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1700000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13500000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q2 srdx Valuation Allowance Percentage
ValuationAllowancePercentage
0.50
CY2024Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
2900000
CY2023Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
3100000
CY2024Q2 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
0
CY2023Q3 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
0
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30341000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
52483000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
92851000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
104614000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5369000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
21412000
us-gaap Operating Income Loss
OperatingIncomeLoss
-5032000
us-gaap Operating Income Loss
OperatingIncomeLoss
7600000
CY2024Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2126000
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2151000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6555000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6365000
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
srdx Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
srdx Non Rule10 B51 Arr Modified Flag
NonRule10B51ArrModifiedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-088249-index-headers.html Edgar Link pending
0000950170-24-088249-index.html Edgar Link pending
0000950170-24-088249.txt Edgar Link pending
0000950170-24-088249-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
srdx-20240630.htm Edgar Link pending
srdx-20240630.xsd Edgar Link pending
srdx-ex31_1.htm Edgar Link pending
srdx-ex31_2.htm Edgar Link pending
srdx-ex32_1.htm Edgar Link pending
srdx-ex32_2.htm Edgar Link pending
srdx-ex3_2.htm Edgar Link pending
srdx-20240630_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable